Navigation Links
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
Date:11/12/2008

edominantly result in antibody responses to CMV have not proven highly effective in transplant patients. Vaccine approaches using live, attenuated viruses can induce both antibody and cellular immune responses, but pose a potential safety concern, particularly for immunocompromised patients, of causing the disease they are intended to prevent. Vical's novel DNA vaccine approach is designed to induce both antibody and cellular immune responses against specific features of the CMV virus without the risk of causing CMV disease. Vical's vaccine has received orphan drug designation for hematopoietic stem cell transplant and solid organ transplant patients.

About Vical

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue developme
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
2. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
3. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
4. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
5. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
6. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
7. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
8. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
9. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
10. Promise of Vicals CMV Vaccine Noted by Independent Experts
11. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 26, 2014  CARsgen, a leader in the development ... treat a variety of cancers, today announced the completion ... China -based healthcare private equity fund. ... on the development of new therapeutics for liver, lung, ... Institute and Shanghai Renji Hospital, the company plans to ...
(Date:11/26/2014)... Nov. 25, 2014  At the American Dental Association,s ... this October, KaVo Kerr Group was honored to be ... attendees the opportunity to see and test the Best ... leaders deliver lectures on the latest developments in dental ... the new DEXIS CariVu Caries Detection Device and Kerr ...
(Date:11/26/2014)... --  Heska Corporation (NASDAQ: HSKA ) - ... advanced veterinary diagnostic and other specialty veterinary products , ... attend The Benchmark Company, LLC,s Micro Cap Discovery Conference on ... at The Palmer House Hilton, 17 E. Monroe Street, ... p.m. Please email hska@haydenir.com or contact your Benchmark ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Heska to Attend Benchmark Micro Cap Discovery Conference 2
... (Nasdaq: VRUS ) today announced that it will ... Study of Liver Diseases (AASLD) on Sunday, October 31, 2010 ... Pharmasset,s progress on the programs that are the subject of ... via the internet, log on to the "Events & Presentations" ...
... Calif., Oct. 27 The following statement is being ... Comden, Casselman & Esensten, LLP regarding the ExtenZe class ... has been reached involving the manufacturer of a male ... Williams, et al. v. Biotab Nutraceuticals, Inc., et ...
Cached Medicine Technology:Pharmasset to Webcast an Investor Event from the AASLD Meeting 2Pharmasset to Webcast an Investor Event from the AASLD Meeting 3If You Bought ExtenZe, You Might Receive Money and Benefits from a Class Action Settlement. 2If You Bought ExtenZe, You Might Receive Money and Benefits from a Class Action Settlement. 3
(Date:11/27/2014)... PA (PRWEB) November 27, 2014 An ... from an embarrassing fact of life, and she wants ... a few minutes later, I decided that there needed ... periods," she said. , Easy to use and producible ... freshness in a woman’s private areas throughout the day. ...
(Date:11/27/2014)... -- Most babies and young children don,t need medicines ... Drug Administration says. Over-the-counter (OTC) cold and cough ... 2 because they could cause serious and potentially deadly ... about three colds a year, but children get them ... want to give them pain relievers, decongestants and other ...
(Date:11/27/2014)... York, NY (PRWEB) November 27, 2014 The ... to offering stylish, comfortable and high functioning compression socks, are ... The newly-released socks use an innovative Gradient Pressure (TM) knitting ... oxygenated blood. , VIM & VIGR’s commitment to adding flair ... of as just functional recently caught the eye of a ...
(Date:11/27/2014)... OXNARD, CA (PRWEB) November 27, 2014 ... All-on-4™ dental implants procedure will help one person ... rehabilitation. , Dr. Saj Jivraj and Dr. Mamaly Reshad ... Woodland Hills, Calif., have launched a website devoted to ... A section of the website would be devoted to ...
(Date:11/27/2014)... California (PRWEB) November 27, 2014 Developers and ... a new plugin entitled ProPip, taking FCPX to the next ... picture effect with a few clicks of a mouse,” said ... time saver that our users will appreciate.” , With ProPip ... customization leaving the possibilities truly endless. ProPip is great for ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3
... http://www.spacapsule.com ), the most advanced method of massage,aromatherapy ... has retained one of Florida,s fastest growing PR ... relaxation experience on,the planet. "We see the ... a matter,of minutes can take you from planet ...
... World-Class Doctors from one of the Nation,s Premier Centers ... Health Care, Research, and Medical Education will Host, ... first-class doctors, NEW YORK, Nov. 12 SIRIUS ... today announced the creation of,"Doctor Radio Powered by NYU ...
... 2007 Rose 12.8% to US$14.3 Million (RMB 107.7 ... Million) Compared to Third Quarter 2006, ... FFHL ), a manufacturer and distributor of,high-quality BOPET plastic ... third quarter and for the nine months,ended September 30, 2007 ...
... November 12 Schlafender Hase GmbH,today released the ... The Text Verification Tool is a patent-protected ... print layout ("artwork") on the data,level - independent ... may be annotated, saved in PDF format and ...
... - Global Landmarks Mark First United Nations World ... will light up in blue to mark the,first United ... the world,s most iconic buildings and sites. The landmarks ... the diabetes circle, the global,symbol for diabetes. The ...
... Families coping with prostate cancer report improved quality of ... patients cancer management, according to a new study. The ... CANCER, a peer-reviewed journal of the American Cancer Society. ... the University of Michigan and co-investigators found that patients ...
Cached Medicine News:Health News:The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR 2Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 2Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 3Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 4Health News:SIRIUS Satellite Radio to Launch 'Doctor Radio,' a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center 5Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 2Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 3Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 4Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 5Health News:Fuwei Films Announces Third Quarter 2007 Financial Results 6Health News:Schlafender Hase Releases Text Verification Tool 4.0 2Health News:World Diabetes Day Lights Up the Skyline 2Health News:World Diabetes Day Lights Up the Skyline 3Health News:Family counseling improves lives of patients and spouses coping with prostate cancer 2
... Esteem™ External Vacuum Therapy System restores sexual ... men. Non-invasive and low cost vacuum therapy, ... desirable outcome", makes it the ideal therapy ... Therapy System causes penile rigidity that can ...
... Special Peristaltic phacoemulsification system features microprocessor control ... programmability and remote control for all settings. ... panel with color coded function modes and ... of use and viewing. Under control of ...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
Medicine Products: